Übersetzung für "Aspiration pneumonia" in Deutsch

Brexpiprazole should be used cautiously in patients at risk for aspiration pneumonia.

Aripiprazole should be used cautiously in patients at risk for aspiration pneumonia.

Aspiration pneumonia is more prevalent in dogs than cats.

Weight loss, respiratory distress (aspiration pneumonia)

If your dog has aspiration pneumonia, it may require intensive care in a hospital setting.

Oxygen may be needed for patients with severe aspiration pneumonia.

Aspiration pneumonia (caused by choking on vomit material)

In rare cases dysphagia followed by aspiration pneumonia and death has been reported.

When the musculature of the oropharynx and oesophagus are affected, aspiration pneumonia may ensue.

In PPMS, patients with swallowing difficulties are at a higher risk of aspiration pneumonia.

Also, aspiration pneumonia may develop due to the entrance of food or liquid into the lungs.

Or, your dog could breath some of the toxin into its lungs, causing aspiration pneumonia.

Aspiration pneumonia can occur when food or liquids are swallowed down the wrong pipe.

However, abnormalities related to underlying diseases or complications, like aspiration pneumonia, may be seen.

Dysphagia should be monitored to decrease the risk of aspiration pneumonia.

Abnormal lung or breathing sounds, such as wheezing and coughing, may be detected in dogs with aspiration pneumonia.

The effects include respiratory depression, acute pulmonary edema, bronchospasm, aspiration of vomit and aspiration pneumonia.

Aripiprazole and other antipsychotic drugs should be used cautiously in patients at risk for aspiration pneumonia.

Adverse reactions related to spread of toxin distant from the site of administration have been reported: exaggerated muscle weakness, dysphagia, dyspnoea, aspiration pneumonia with fatal outcome in some cases (see section 4.4).

Quetiapine should be used with caution in patients at risk for aspiration pneumonia.

Death due to AEs on therapy or within 30 days from the last dose of study drug were 5 (1.9%) vs 3 (1.2%) (investigational arm: pulmonary embolism in 2 subjects, acute respiratory failure, aspiration and pneumonia in one patient each; control arm: cerebrovascular accident, ischemic stroke and sepsis, each in one patient).

Symptoms of overdose are not immediately apparent post-injection and may include general weakness, ptosis, diplopia, swallowing and speech difficulties or paralysis of the respiratory muscles resulting in an aspiration pneumonia.

Side effects related to spread of toxin distant from the site of administration have been reported (exaggerated muscle weakness, dysphagia, dyspnoea, aspiration pneumonia with fatal outcome in some cases) (see section 4.4).